Clinical Impact of Tumoral Angiogenesis on Renal Cell Carcinoma Management: Where Do We Stand?

Expert Review of Precision Medicine and Drug Development - United Kingdom
doi 10.1080/23808993.2016.1181974
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Targeting Angiogenesis in Cancer Treatments: Where Do We Stand?

Journal of Pharmacy and Pharmaceutical Sciences
MedicinePharmacologyPharmaceutical Science
2016English

Transitional Cell Carcinoma of the Bladder in Pediatric Patients: Where Do We Stand?

Urologia Colombiana
Urology
2020English

Editorial Paper Renal Denervation – Where Do We Stand in 2014?

Postepy w Kardiologii Interwencyjnej
Cardiovascular MedicineCardiology
2014English

High Energy Neutrino Astronomy: Where Do We Stand, Where Do We Go?

Physics of Particles and Nuclei
High Energy PhysicsNuclear
2018English

Schistosomiasis Vaccines: Where Do We Stand?

Parasites and Vectors
ParasitologyInfectious Diseases
2016English

Where Do We Stand After Coty?

Competition Law Journal
2018English

Blockchain in Academia: Where Do We Stand and Where Do We Go?

2020English

Quantum Computers: Where Do We Stand?

Europhysics News
AstronomyPhysics
2005English

Using Electronic Health Records for Clinical Trials: Where Do We Stand and Where Can We Go?

CMAJ
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy